Researchers Published Porcine SCID Model Dataset
The research-stage multi-omic dataset offers new parameters for investigating immune deficiency pathophysiology.
Updated on Sept. 22, 2026 in Life Sciences
Researchers have published a comprehensive multi-omic dataset for a porcine RAG2-deficient severe combined immunodeficiency (SCID) model. This research-stage resource provides genomic and transcriptomic profiles to support the study of immune system development.
Why it matters
This dataset serves as a foundational resource for benchmarking therapeutic interventions and modeling the pathophysiology of SCID in a non-rodent system. It allows researchers to better map gene-immune interactions using high-resolution molecular profiles.
The dataset centers on a model featuring a single-amino-acid deletion (p.His109del) in the RAG2 gene. It includes flow cytometry data confirming the absence of mature adaptive lymphocytes, alongside RNA-seq transcriptomic profiles and H3K4me3 ChIP-seq data.
The details
Researchers created the model using TALEN (transcription activator-like effector nuclease) editing, a method that uses custom proteins to create targeted double-strand breaks in DNA. The resulting tissue analysis reveals thymic aplasia—the failure of the thymus to develop—and splenic hypoplasia, an underdeveloped spleen. These histopathological findings, paired with the sequencing data, detail how the RAG2 mutation disrupts immune maturation.
Timeline
September 22, 2026: The article and dataset were published online.
The Tech Race
This work represents a departure from traditional murine models by establishing a more complex physiological benchmark for SCID research. It advances the race to develop accurate non-rodent systems for translating gene-editing therapies into clinical settings.
This dataset provides a standard reference for immunologists and biotech researchers working to validate new therapeutic interventions. It does not affect clinical care or public health directly but accelerates the early-stage research pipeline for future SCID treatments.
The takeaway
Researchers can now utilize these high-resolution profiles to refine gene-editing benchmarks in immunology. Watch for follow-up studies that apply this dataset to test the efficacy of novel hematopoietic interventions in porcine models.
Further reading
For broader context on animal model innovation, visit Life Sciences.
Source note: This article includes information reported by Nature.
